Vertex Pharmaceuticals Inc
VRTX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of VRTX by members of U.S. Congress
VRTX Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
VRTX Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
VRTX Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by VRTX's directors and management
Government lobbying spending instances
-
$970,000 Jan 17, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$1,000,000 Oct 18, 2024 Issue: Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$980,000 Jul 15, 2024 Issue: Medicare/Medicaid Health Issues
-
$1,150,000 Apr 18, 2024 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$80,000 Apr 09, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Budget/Appropriations
-
$60,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 22, 2024 Issue: Health Issues
-
$30,000 Jan 20, 2024 Issue: Budget/Appropriations Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
-
$80,000 Jan 12, 2024 Issue: Health Issues Medicare/Medicaid
-
$890,000 Oct 19, 2023 Issue: Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Health Issues
-
$630,000 Jul 19, 2023 Issue: Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Health Issues
-
$370,000 Jan 18, 2023 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Health Issues
-
$710,000 Oct 14, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Health Issues
-
$520,000 Jul 19, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$520,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$630,000 Jan 20, 2022 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$450,000 Oct 20, 2021 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
-
$420,000 Jul 19, 2021 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$570,000 May 21, 2021 Issue: Health Issues Medicare/Medicaid
-
$410,000 Apr 19, 2021 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$380,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$380,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$390,000 Apr 20, 2020 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$530,000 Jan 21, 2020 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$310,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$310,000 Jul 22, 2019 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$320,000 Apr 19, 2019 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$450,000 Jan 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$340,000 Oct 19, 2018 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$350,000 Jul 18, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$350,000 Apr 19, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$340,000 Jan 19, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$340,000 Oct 19, 2017 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$560,000 Jul 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$450,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$340,000 Jan 20, 2017 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$350,000 Oct 20, 2016 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$440,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$210,000 Apr 20, 2016 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$350,000 Jan 19, 2016 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$330,000 Oct 20, 2015 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$300,000 Jul 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$380,000 Apr 20, 2015 Issue: Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid
-
$210,000 Jan 19, 2015 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$280,000 Oct 16, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$480,000 Jul 21, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$190,000 Apr 21, 2014 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
-
$210,000 Jan 20, 2014 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$210,000 Oct 21, 2013 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$460,000 Jul 18, 2013 Issue: Health Issues
-
$300,000 Apr 22, 2013 Issue: Health Issues
-
$260,000 Jan 22, 2013 Issue: Budget/Appropriations Health Issues
-
$250,000 Oct 19, 2012 Issue: Health Issues Budget/Appropriations
-
$360,000 Jul 20, 2012 Issue: Budget/Appropriations Health Issues
-
$490,000 Apr 20, 2012 Issue: Health Issues Budget/Appropriations
-
$480,000 Jan 19, 2012 Issue: Health Issues Budget/Appropriations
-
$360,000 Oct 20, 2011 Issue: Health Issues Budget/Appropriations
-
$450,000 Jul 19, 2011 Issue: Health Issues
-
$460,000 Apr 20, 2011 Issue: Health Issues
-
$140,000 Jan 19, 2011 Issue: Health Issues
-
$370,000 Oct 20, 2010 Issue: Health Issues
-
$170,000 Jul 20, 2010 Issue: Health Issues
-
$300,000 Apr 20, 2010 Issue: Health Issues
-
$120,000 Jan 20, 2010 Issue: Health Issues
-
$130,000 Oct 20, 2009 Issue: Health Issues
-
$130,000 Jul 20, 2009 Issue: Health Issues
-
$180,000 Apr 20, 2009 Issue: Health Issues
-
$100,000 Jan 21, 2009 Issue: Health Issues
-
$120,000 Oct 20, 2008 Issue: Health Issues
-
$80,000 Jul 21, 2008 Issue: Health Issues
-
$80,000 Apr 21, 2008 Issue: Science/Technology Medical/Disease Research/Clinical Labs Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Health Issues
Estimated quarterly lobbying spending
VRTX Revenue by Segment or Geography
By Segment
By Geography
VRTX Income Statement
VRTX Balance Sheet
VRTX Cash Flow
U.S. Patents
New patents grants
-
Patent Title: Compounds useful as inhibitors of atr kinase and combination therapies thereof Sep. 07, 2021
-
Patent Title: Modulators of atp-binding cassette transporters Aug. 10, 2021
-
Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators Jul. 20, 2021
-
Patent Title: Pteridinone compounds and uses thereof Jul. 13, 2021
-
Patent Title: Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof Jul. 06, 2021
-
Patent Title: Dna-pk inhibitors Jun. 01, 2021
-
Patent Title: Dna-pk inhibitors May. 18, 2021
-
Patent Title: Modulators of atp-binding cassette transporters Apr. 27, 2021
-
Patent Title: Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases Apr. 20, 2021
-
Patent Title: Modulators of atp-binding cassette transporters Apr. 13, 2021
-
Patent Title: Substituted quinoxaline dna-pk inhibitors Apr. 13, 2021
-
Patent Title: Substituted pyrazines as atr kinase inhibitors Mar. 30, 2021
-
Patent Title: 2,7-dibromospiro[fluorene-9,4′-piperidine] compounds Feb. 09, 2021
-
Patent Title: Deuterated cftr potentiators Jan. 19, 2021
-
Patent Title: Inhibitors of influenza viruses replication Dec. 29, 2020
-
Patent Title: Inhibitors of influenza viruses replication Dec. 29, 2020
-
Patent Title: Processes for preparing atr inhibitors Nov. 03, 2020
-
Patent Title: Compounds useful as inhibitors of atr kinase Oct. 27, 2020
-
Patent Title: Treating cancer with atr inhibitors Oct. 27, 2020
-
Patent Title: Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates thereto Oct. 20, 2020
-
Patent Title: Influenza a virus variants Oct. 13, 2020
-
Patent Title: Influenza a virus variants Oct. 13, 2020
-
Patent Title: Compounds useful as inhibitors of atr kinase Oct. 13, 2020
-
Patent Title: Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Oct. 06, 2020
-
Patent Title: Prodrugs of pyridone amides useful as modulators of sodium channels Sep. 29, 2020
-
Patent Title: Compounds useful as inhibitors of atr kinase Sep. 29, 2020
-
Patent Title: Dna-pk inhibitors Sep. 29, 2020
-
Patent Title: Triazoles for the treatment of demyelinating dieases Sep. 08, 2020
-
Patent Title: Deuterated cftr potentiators Sep. 01, 2020
-
Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator Sep. 01, 2020
-
Patent Title: Materials and methods for treatment of hemoglobinopathies Aug. 11, 2020
-
Patent Title: Deuterated cftr modulators Aug. 11, 2020
-
Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator Aug. 11, 2020
-
Patent Title: Pyridone amides as modulators of sodium channels Aug. 11, 2020
-
Patent Title: Co-crystals and pharmaceutical compositions comprising the same Jul. 21, 2020
-
Patent Title: Mannose derivatives for treating bacterial infections Jun. 02, 2020
-
Patent Title: Modulators of atp-binding cassette transporters May. 26, 2020
-
Patent Title: Crystalline forms and compositions of cftr modulators May. 19, 2020
-
Patent Title: Carboxamides as modulators of sodium channels May. 12, 2020
-
Patent Title: Pharmaceutical composition and administrations thereof May. 12, 2020
-
Patent Title: Methods of preparing inhibitors of influenza viruses replication May. 05, 2020
-
Patent Title: Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Feb. 25, 2020
-
Patent Title: Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Jan. 21, 2020
-
Patent Title: Methods of preparing inhibitors of influenza viruses replication Jan. 14, 2020
-
Patent Title: Dna-pk inhibitors Dec. 10, 2019
-
Patent Title: Substituted pyrazin-2-amines as inhibitors of atr kinase Nov. 19, 2019
-
Patent Title: Compounds useful as inhibitors of atr kinase and combination therapies thereof Nov. 19, 2019
-
Patent Title: Dna-pk inhibitors Oct. 15, 2019
-
Patent Title: Processes for preparing atr inhibitors Oct. 08, 2019
-
Patent Title: Mannose derivatives for treating bacterial infections Sep. 10, 2019
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
VRTX News
Recent insights relating to VRTX
WallStreetBets
Number of mentions of VRTX in WallStreetBets Daily Discussion
CNBC Recommendations
Recent picks made for VRTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in VRTX
VRTX Analyst Ratings
VRTX Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
VRTX Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $VRTX stock a Buy, Sell, or Hold?
- What is the price target for $VRTX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
VRTX Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $VRTX stock?
- Who owns the most shares of $VRTX stock?
- What funds own $VRTX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
VRTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view VRTX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More